The certification enables the reagent maker to create optimizing products for use beyond the research market.
CBC also recently achieved ISO DIN/EN 17025:2005 accreditation for the extraction of total RNA from body fluids and the analysis of microRNA and mRNA.
The Center for Human Genetics and Laboratory Medicine's Prenatalis test is based on Illumina's Verifi technology.
The recertification covers design, production, and sale of the firm's qNPA technology-based gene expression analysis products and services.
The company achieved ISO 13485 certification for two facilities, extending their capabilities to manufacture and offer raw materials used in diagnostic assays.
The certification covers the development, production, and distribution of in vitro diagnostics for autoimmune disease.
The test uses mitochondrial DNA hybridization arrays to detect up to 21 animals that are ingredients or contaminants in food for humans, pets, and livestock.
The New Zealand-based cancer diagnostics firm received ISO 15189:2012 accreditation.
The certification follows CLIA certification and CAP accreditation for the firm's Cambridge, Mass. next-generation sequencing laboratory.
The accreditation is for Illumina-based sequencing services and covers HiSeq and MiSeq sequencing, RNA and DNA library preparation, and other services.
British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.
Vox reports on inequities in genetic research and efforts to address them.
The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.
In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.